Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis
Megan Shurey, Ashley Yip, Olga Ziouzina, Jonathan Chan, Jan P. Dutz
Topics & Concepts
MedicineTofacitinibCombination therapyPsoriatic arthritisRefractory (planetary science)Internal medicineDermatologyRheumatoid arthritisOncologyArthritisMethotrexateAntirheumatic AgentsMEDLINEPharmacotherapyPsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders Research